Key result
AI-enabled ECG accurately identifies occult cardiovascular disease, but hard preventive clinical benefits remain unproven.
Why the study?
Conventional ECG interpretation captures only a fraction of the cardiac electrical signal, and while AI-ECG alerts may improve outcomes in selected high-risk populations, whether such benefits extend to preventive populations remains uncertain.
Does artificial intelligence-enabled ECG screening improve cardiovascular disease detection, risk stratification, and clinical outcomes in preventive populations?
Does artificial intelligence-enabled ECG screening improve cardiovascular disease detection, risk stratification, and clinical outcomes in preventive populations?
Answers are grounded in this paper and cite their sources.
This narrative review highlights that while AI-enabled ECG analysis can detect latent cardiovascular disease and stratify risk, translating these predictions into clinical preventive value requires coupling them with validated diagnostic pathways and actionable interventions.
The electrocardiogram (ECG) is an established tool in cardiovascular prevention, identifying silent arrhythmias, hypertrophy, prior myocardial infarction, conduction disease, and inherited electrical disorders. However, conventional interpretation captures only a fraction of the information embedded in the cardiac electrical signal. Because the ECG is inexpensive, non-invasive, standardized, and already acquired at scale, it provides an attractive substrate for artificial intelligence (AI)-enabled screening and risk stratification. Deep-learning models can identify latent signatures of ventricular dysfunction, structural heart disease, atrial fibrillation, cardiomyopathy, heart failure, and mortality risk. Importantly, evidence is beginning to extend beyond retrospective validation: prospective implementation studies have increased disease detection, while randomized data suggest that AI-ECG–guided clinical alerts may improve outcomes in selected high-risk populations. Whether such benefits extend to preventive populations remains uncertain. This review examines the preventive role of conventional, ambulatory, and wearable ECGs and distinguishes AI applications for detection, prediction, prognostication, treatment selection, and longitudinal monitoring. We argue that performance metrics alone are insufficient. Preventive value requires a defined target population, calibrated and externally validated predictions, an appropriate confirmatory test, a feasible clinical workflow, and an intervention proven to improve outcomes. The most credible near-term applications are those that triage patients to established diagnostic pathways, such as echocardiography or prolonged rhythm monitoring. The central challenge is therefore to transform accurate AI-ECG predictions into actionable, affordable, scalable, safe, and equitable prevention.
No takes yet. Share an insight, caveat, or question.
Garcia et al. (2026) conducted a review in Cardiovascular disease prevention. AI-enabled electrocardiogram (AI-ECG) vs. Conventional ECG interpretation was evaluated. AI-enabled ECG detects latent cardiovascular disease and triages patients to diagnostic pathways, though translating predictions into proven preventive outcomes remains uncertain.
Synapse has enriched 10 related papers. Consider them for comparative context: